Top Markets
Coin of the day
Augmedix, Inc. Augmedix, Inc.

Augmedix, Inc.

AUGX
Rank in Stocks #22478
Augmedix, Inc. is a U.S.-based company specializing in remote medical... Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Share Price
$2.35
Last synced: 2024-10-02
Market Cap
$87.95M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Augmedix, Inc. (AUGX)

Category

P/E ratio for Augmedix, Inc. (AUGX)
P/E ratio as of August 2026 TTM: -5.33
According to Augmedix, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.33. At the end of 2022 the company had a P/E ratio of -2.20.
P/E ratio history for Augmedix, Inc. from 2018 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -5.33 -60.26%
2023 -13.41 509.41%
2022 -2.20 -58.54%
2021 -5.31 -40.39%
2020 -8.90 4,690.16%
2019 -0.19 -54.46%
2018 -0.41 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
21.18 -497.32%
US
79.49 -1,591.57%
AU
-36.43 583.62%
US
43.15 -909.72%
US
- -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.